PDGFR Tyrosine Kinase Inhibitor VII
CAS: 251356-45-3
Ref. 3D-BKA35645
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Product Information
PDGFR Tyrosine Kinase Inhibitor VII is a protein-based drug that binds to the PDGFR tyrosine kinase receptor and inhibits its activity. This binding prevents the activation of the PDGFR, which is necessary for cell signaling. PDGFR Tyrosine Kinase Inhibitor VII has been shown to be effective against cancer cells in vitro and in vivo. It is also used as a complementary treatment for patients with chronic myelogenous leukemia. The mechanism of action of PDGFR Tyrosine Kinase Inhibitor VII is to inhibit the growth and spread of cancer cells by preventing them from proliferating.
Chemical properties
Technical inquiry about: 3D-BKA35645 PDGFR Tyrosine Kinase Inhibitor VII
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
